Skip to main content
Inactivation of bone morphogenetic protein 2 may predict clinical outcome and poor overall survival for renal cell carcinoma through epigenetic pathways
Published Web Location
http://europepmc.org/articles/PMC4496240?pdf=renderNo data is associated with this publication.